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DESCRIPTION of CASE
A 
63-year-old man presented to our accident and 
emergency department with a 2-hour history of 
crushing central chest pain, excessive sweating, and 
difﬁ  culty in breathing. Past history included non-insulin-
dependent diabetes mellitus controlled by oral hypoglycaemic 
agents. 
On examination, he appeared unwell, with pulse of 94 
beats per minute, blood pressure of 124/68 mm Hg, and 
respiratory rate of 20 breaths per minute. Jugular venous 
pressure was not elevated, but chest auscultation revealed 
bilateral basal crackles. Cardiovascular system examination 
was unremarkable. His electrocardiogram on admission 
showed >2 mm ST segment elevation in chest leads V1–V4 
(Figure 1A). 
What Was the Clinical Diagnosis and Treatment?
The combination of typical chest pain and 
electrocardiographic changes were characteristic of acute 
anteroseptal myocardial infarction. A presumptive diagnosis 
of probable left anterior descending (LAD) coronary artery 
occlusion was made. Our patient was promptly thrombolysed 
with recombinant plasminogen activator and managed as per 
our hospital’s acute myocardial infarction (AMI) protocol. 
This involved administration of diamorphine, aspirin, 
intravenous nitrates, heparin, a beta-blocker, an angiotensin 
converting enzyme inhibitor, and a statin. 
Within 30 minutes of thrombolytic therapy, there was 
complete cessation of pain and subsidence of elevated ST 
segments (Figure 1B). His peak CK and CK-MB were elevated 
at 577 IU and 68 IU, respectively. Wall motion abnormalities 
on transthoracic echocardiogram were identiﬁ  ed in the 
resting LAD territory. His further stay in the coronary care 
unit was uneventful.
What Was the Subsequent Differential Diagnosis?
Our patient presented with electrocardiogram changes of 
a myocardial infarction (MI). Although this is most likely 
due to coronary occlusion, the ST elevation may occur for 
reasons other than infarction (Box 1). Moreover, infarction 
need not result from coronary occlusion (Box 2). The 
electrocardiogram and echocardiogram thus both suggested 
a high probability of ischemia in the LAD territory. In order 
to stratify our patient’s prognosis, it would be important to 
determine whether the patient did indeed have the implied 
single vessel (LAD) coronary artery disease and whether the 
infarct territory was optimally revascularised at macro- and 
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Figure 1. Electrocardiogram on Admission and after Thrombolytic 
Therapy
(A) Electrocardiogram on admission showing >2 mm ST elevation in 
chest leads V1–V4.
(B) Electrocardiogram after thrombolytic therapy showing subsidence of 
elevated ST segments.
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microvascular levels. As part of post-MI risk stratiﬁ  cation, our 
patient underwent vasodilator stress radionuclide perfusion 
and myocardial contrast echocardiography (MCE). 
Radionuclide imaging (Figure 2) showed a reversible 
perfusion defect in the septum as shown by decreased tracer 
concentration after stress in the whole of the septum (seen 
in the short axis view). This defect indicated ﬂ  ow-limiting 
coronary artery disease in the LAD territory as suspected from 
the preliminary clinical assessment. 
MCE is shown in Figure 3. In Figure 3A, an apical 
three-chamber view assessment at rest demonstrates a 
correspondingly reduced contrast uptake in the apical sub-
endocardium representing an infarcted region, whilst the 
remaining myocardium shows normal opaciﬁ  cation. In Figure 
3B, an apical three-chamber view assessment following stress 
demonstrates markedly reduced contrast uptake in the entire 
septum, suggesting mid-LAD disease.
What Was the Final Diagnosis and Treatment?
The patient underwent coronary angiography, which showed 
ﬂ  ow-limiting coronary stenosis in the mid-LAD (Figure 4 
and Video S1). This was successfully treated with coronary 
angioplasty with stent implantation before discharge from 
hospital.
DISCUSSION
Major advances have been made in reperfusion therapy 
for AMI. Pharmacological developments have led to the 
introduction of recombinant thrombolytic therapies, which are 
increasingly safe and effective [1]. Moreover, the widespread 
application of catheter-based therapy, be this in the guise of 
primary or facilitated angioplasty, have dramatically delivered 
on the promise of reduced short-term and long-term AMI-
related mortality [2]. This success derives from the expeditious 
salvage of vulnerable but viable myocytes threatened by 
occlusion of upstream vasculature by the clearance of ﬂ  ow-
limiting arterial disease. Such salvage translates into retained 
myocardial function and increased chances of survival [3]. 
Assessing the Success of Thrombolysis
However, pharmacological or mechanical reperfusions 
are not without risk and ﬁ  nancial burden, and should be 
preferentially directed to a viable myocardium [4]. Effective 
reperfusion should therefore aim to reinstate the macro- 
and microvascular supply to only living myocytes. Ideally, a 
patient undergoing emergent thrombolytic therapy should be 
evaluated to see whether thrombolysis was successful. If it was 
unsuccessful, the patient should be immediately referred for 
rescue angioplasty. 
Even if thrombolysis appears to be clinically successful, as 
in our patient, before more elective interventional therapy 
is considered it is prudent to quantify what proportion 
of dysfunctional myocardium may be viable and hence 
salvageable. This proportion is a marker of a patient’s 
prognosis. Moreover, even if angioplasty—a therapy that is 
fast becoming the standard of care worldwide—rather than 
thrombolysis is the primary therapy for the AMI, assessing 
myocardial perfusion or lack thereof still informs prognosis. 
(In most cases an epicardial coronary vessel recanalised 
by angioplasty should establish ﬂ  ow at the microvascular 
coronary level; this may not happen in all cases and ﬂ  ow 
to the infarct myocardium may be diminished despite the 
angiographic documentation of reﬂ  ow in the infarct-related 
artery; this is termed “no-reﬂ  ow.”) [5]
How would these patients be stratiﬁ  ed? Although clinical 
features such as the relief of pain and the absence of 
electrocardiographic Q waves have widely been regarded to 
imply a good response to thrombolysis and hence a residual 
mass of viable myocardium, they have been shown to be 
imprecise [6]. More recently, other imaging modalities 
have been advocated for the evaluation of myocardial 
viability, including radionuclide techniques, dobutamine 
echocardiography, magnetic resonance, and positron 
emission tomography [7]. 
A New Technique for Assessing Myocardial Viability
MCE has emerged as one of the most effective of these 
modalities and has the added beneﬁ  t of being available 
immediately at the patient’s bedside; broadly, this technique 
relies on the application of echocardiographic ultrasound 
waves to intravascular microbubble contrast media that 
reﬂ  ect these signals (echoes) [8,9]. Microbubbles are 
stable bubbles of gas encased in polymeric shells. By 
careful design of the shells and the microbubbles, strong 
echoes are produced by the acoustic impedance mismatch. 
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Figure 2. Radionuclide Imaging Showing a Reversible Perfusion 
Defect in the Septum 
The defect is shown by decreased tracer concentration (white arrows) in 
the whole of the septum after stress (seen in the short axis view).
Box 1. Causes of ST-Elevation in the Absence of MI
Normal variant; often an ethnic variant in African-American 
males
Left ventricular hypertrophy
Pericarditis
Hyperkalaemia
Brugada syndrome
Periresuscitation
Neurological events (e.g., seizure, subarachnoid haemorrhage)
Post-cardioversion
Pulmonary embolismPLoS Medicine  |  www.plosmedicine.org 0318
Furthermore, serendipitously, the size and constitution 
of the bubbles ensures that they coincidentally resonate 
within the frequency of normal cardiac ultrasound; they 
thus further improve signal-to-noise ratio. They are conﬁ  ned 
solely to the vasculature, and hence their presence and 
density is a surrogate for blood capillary volume. Resting 
contrast absence implies a non-viable myocardium, since 
these segments have chronically been starved of blood-
delivered nutrients. Conversely, the presence of contrast 
implies a potentially viable myocardium as these regions are 
perfused. Finally, stress-induced contrast deﬁ  ciencies imply a 
myocardium that is vulnerable due to vascular compromise.
How does MCE compare with other imaging modalities? 
Technetium-99m Sestamibi single-photon emission computed 
tomography is the most commonly used clinical imaging 
modality assessing myocardial perfusion; it has been 
successful in predicting coronary stenosis. A number of 
studies have compared these two modalities in the context 
of coronary artery disease and have broadly shown that MCE 
was equal or superior to single-photon emission computed 
tomography during dipyridamole stress for the diagnosis of 
coronary artery disease [10]; MCE does so at the bedside 
without the concomitant radiation risks. 
In the speciﬁ  c setting of MI, by demonstrating an area of 
impaired perfusion (through microbubble paucity) MCE 
can deﬁ  ne the vulnerable myocyte territory and make the 
diagnosis of MI efﬁ  ciently [11]. In doing so, it can also specify 
the vessel that subtends this territory and is compromised by 
vessel occlusion. Once an intervention is performed, contrast 
studies can demonstrate the reversal of microbubble paucity 
and therefore adjudicate the success of revascularisation [12]. 
Importantly, as the most compelling prognostic factors after 
MI are the extent of myocyte loss, myocardial remodelling, 
and the resulting myocardial dysfunction, by quantifying 
the residual non-perfused myocardium an accurate estimate 
of dysfunctional myocardium can be made with immediate 
prognostic value. MCE can therefore predict the extent of 
residual myocardial viability and the degree of LV remodelling 
after MI [13]. It is important to note that in patients with a 
medium probability of coronary artery disease and no prior MI, 
MCE was at least as effective as the widely used radionuclide 
imaging [14]. Moreover, MCE correlates well with radionuclide 
imaging in patients with AMI post-revascularisation [15].
Indicating the value of MCE, in a recent study of >1,000 
patients with chest pain presenting to an emergency 
department, MCE was found to be the best predictor of both 
short-term (48 hours) and long-term (up to 2 years) outcome 
(death, MI, revascularisation, unstable angina, and congestive 
heart failure). Unlike data collected from other modalities, 
MCE data were available immediately at the bedside after 
hospital presentation, and they remained superior even 
after all clinical, electrocardiographic, and serum biomarker 
information were taken into account [16].
Limitations
While the literature strongly advocates the use of perfusion 
imaging to assess the presence of coronary artery disease 
and to direct further therapy, perfusion imaging in general 
and MCE in particular do have some limitations. The ﬁ  rst 
and most important limitation is that of training; clearly, 
Box 2. Causes of ST-Elevation MI in the Absence 
of Coronary Disease
Coronary thrombosis, due to coagulopathy (e.g., 
homocysteinaemia, protein C/S deﬁ  ciency, and use of oral 
contraceptives) 
Vasculitis (e.g., Kawasaki syndrome and collagen disorders)
Cocaine
Coronary spasm
Embolic events (e.g., paradoxical emboli from patent foramen 
ovale or endocarditis)
Congenital coronary anomalies
Metabolic toxicity (e.g., carbon monoxide)
Drug-induced infarction (e.g., albuterol)
Pulmonary embolism
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Figure 3. MCE: Apical Three-Chamber View Assessment
(A) Apical three-chamber view assessment at rest. This assessment 
demonstrates a correspondingly reduced contrast uptake in the apical 
sub-endocardium representing an infarcted region (two black arrows) 
whilst the remaining myocardium shows normal opaciﬁ  cation. 
(B) Apical three-chamber view assessment following stress. This 
assessment demonstrates markedly reduced contrast uptake in the 
entire septum (black arrows) suggesting mid-LAD disease.PLoS Medicine  |  www.plosmedicine.org 0319 March 2006  |  Volume 3  |  Issue 3  |  e131
the application of this novel technique relies on specialist 
expertise. In order for “real-world” studies to reﬂ  ect existing 
studies, a signiﬁ  cant learning curve will have to be traversed. 
Secondly, while readily available, at present no microbubble 
contrast agents have been licensed for clinical practice. 
Although it is likely that they will be licensed, it is important 
to complete large-scale studies for regulatory bodies to be 
satisﬁ  ed that these agents are free of deleterious bioeffects. 
To date, such studies have conﬁ  rmed the safety and utility 
of these agents. Ultimately, the clinical application of MCE 
must be tempered with the knowledge that the capacity of 
perfusion analysis is limited in myocardial segments such as 
the baso-lateral walls that are prone to greater errors.
Conclusion
MCE is a rapid bedside method for assessing myocardial 
perfusion. Among other cardiovascular conditions, and as 
with other forms of perfusion imaging, MCE in MI provides 
signiﬁ  cant diagnostic information both in the acute sense 
and with regard to revascularisation strategy. Ultimately, 
these microbubbles can also be generated carrying 
therapeutic agents or carrying receptors or ligands within 
their membranes. They may, therefore, provide a means to 
direct intravascular treatments speciﬁ  cally to the site of active 
disease, as envisaged by Ehrlich when he described his magic 
bullet therapy [17].  
Supporting Information
Video S1. Coronary Angiography Showing Flow-Limiting Coronary 
Stenosis in the Mid-LAD 
You will need RealPlayer to view this video ﬁ  le.
Found at DOI: 10.1371/journal.pmed.0030131.sv001 (463 KB AVI)
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Key Learning Points
•  Non-invasive perfusion imaging such as MCE, radionuclide 
techniques, dobutamine echocardiography, magnetic 
resonance, and positron emission tomography have all been 
shown to have value in diagnosing coronary artery disease.
•  MCE is a new echocardiographic modality that relies on 
microbubbles to scatter ultrasound efﬁ  ciently and hence 
improve imaging.
•  Because they are conﬁ  ned to the vasculature, contrast agents 
provide a unique red-cells view of myocardial perfusion. 
•  By assessing rate of perfusion and myocardial volume, tissue 
perfusion, and hence myocardial viability, can be accurately 
quantiﬁ  ed.
•  An assessment of viability can guide immediate and 
subsequent treatment strategies in patients with a variety of 
cardiac conditions, including MI. 
•  Fast becoming the standard of care in the treatment of AMI, 
MCE provides prognostic value even for patients undergoing 
primary angioplasty.
•  While indicated for only diagnostic purposes at present, the 
capacity to load microbubbles with active therapy (drug 
or gene) and rupture them at will with ultrasound at the 
site of disease promises that they will be used for directed 
therapeutic purposes.
•  MCE carries a learning curve: the dissemination of MCE must 
be carried out with speciﬁ  c attention to technical excellence 
and training to ensure that existing trial results can be 
adequately translated to real-world patient care.
•  When microbubbles are ultimately licensed, ascent of the 
learning curve, coupled with an appreciation of the myocardial 
segments and circumstances that may limit the accuracy of 
the technique, will ensure optimal patient outcomes.
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